Decipher Labs Ltd
Decipher Labs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Decipher Labs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Decipher Labs Ltd Share Price Chart
Decipher Labs Ltd Fundamentals
Traded Volume: null
Market Cap(Cr): null
Avg Traded Price null
1 Year return %
Upper Circuit null
Lower Circuit null
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) null
EPS TTM NaN
Book value NaN
Dividend null%
Decipher Labs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Decipher Labs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Decipher Labs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W null%
1M null%
3M null%
1Y null%
YTD null%
Decipher Labs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Decipher Labs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday null
Day Before Yesterday null
1W Avg null
1M Avg null
3M Avg null
Decipher Labs Ltd Technical Details
Decipher Labs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 null
Support 2 null
Support 3 null
Pivot Point : null
Resistance 1 null
Resistance 2 null
Resistance 3 null
Decipher Labs Ltd Corporate Actions
Decipher Labs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Decipher Labs Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by null
Bonus
No Bonus has been declared by null
Splits
No Split has been declared by null
Others
Rights No Rights has been declared by null
Decipher Labs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Decipher Labs Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Decipher Labs Ltd's relative performance and valuation against major competitors.
Stock Name Colinz Laboratories Ltd ₹43.50 (+9.27%) M. Cap (Cr) 0.20 1 Yr Return (%) -31.27% P/E (TTM) 22.58 PB Ratio 1.10
Decipher Labs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Decipher Labs Ltd, across its operating activities, investing activities, and financing activities.
Decipher Labs Ltd Shareholding Pattern
This shows the ownership breakdown of Decipher Labs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter null%
Public null%
Other Institutions null%
FII null%
Mutual Funds null%
About Decipher Labs Ltd
Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September, 1986 and was converted into a Public Limited Company in Jun.`92. The company was promoted by Suchit Mohan Lal and Ajay Karan. The Company is a professionally managed, well established, diversified Public Limited Company, engaged in the Manufacture & Marketing of Pharmaceuticals and allied products and services and providing Services and key Solutions in Information Technology Industry. Since inception, the Company has been manufacturing & marketing its branded formulations and custom manufacturing for various companies besides supplies of various Bulk drugs, chemicals and Finished Formulations. During the years of operations, it has garnered a reputation as a quality provider in the Pharmaceutical industry and the Products marketed by the Company have been well accepted by the Trade and Medical Fraternity across India.? The Company also diversified interest in the field on Information Technology and has developed a name for itself as a key solution provider in the field of associated technologies. It expanded by reviving the Information Technology wing and started dealing and reviving its associations into the Information Technology Industry. To increase presence in the Information Technology segment, the Company acquired Decipher Software Solutions LLC in USA to add good volumes to the overall turnover and Profits of the Company. The Company came out with a public issue of 23.23 lac equity shares at par aggregating Rs 2.32 cr in Nov.`94. The proceeds of the issue were utilised to part-finance a Rs 3.25-cr project to expand the existing manufacturing facilities for pharmaceutical formulations and to diversify into the manufacture of sterile powder injectables. CDL started commercial production in Jul.`87 on a loan-licence basis. The company acquired a full-fledged manufacturing unit located at Balanagar, Hyderabad, on lease from Fairchild Laboratories and commenced commercial production in Aug.`88. In Jul.`92 the manufacturing activities were shifted to the present leased premises at Kushaiguda, Hyderabad. In this unit various pharmaceutical formulations such as tablets, capsules and liquids are being manufactured. The product range of CDL comprises vital anti-bacterial drugs, antibiotic drugs, anti-inflammatory drugs, haematenic drugs and protein tonic. CDL has developed in-house technology for the manufacture of dispersible and sustained release formulations. The company is exploring the possibilities of exporting its products to Nigeria and West Indies. During the year 1995-96, the expansion programme undertaken by the company was successfully completed and the unit at Yellampet has become operational. During 1996-97, the company has expanded its operations to new areas. It has expanded its product range by introduction of Liquid Orals. The product "HB 2" has been well accepted in the market. The company has also filled its application for obtaining the (c)GMP and WHO GMP Certificate.
Executive Director
Sushant Mohan Lal
Registered office 4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2, Hyderabad, Telangana, 500034
FAX :null
Background
Incorporation Year 1986
Face Value ₹10.00
Market Lot 100
FAQs on Decipher Labs Ltd
How to buy Decipher Labs Ltd shares on NSE?
To buy Decipher Labs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Decipher Labs Ltd share price today?
The Decipher Labs Ltd share price on NSE is ₹N/A today.
What is the market cap of Decipher Labs Ltd on NSE?
The company has a market capitalization of ₹N/A.
What is the PE & PB ratio of Decipher Labs Ltd?
PE is N/A and PB is N/A.
What is the 52 Week High and Low of Decipher Labs Ltd shares?
Decipher Labs Ltd stock price high: ₹N/A Decipher Labs Ltd stock price low: ₹N/A.